US Stock MarketDetailed Quotes
PACB Pacific Biosciences of California
- 1.595
- -0.260-14.02%
Close Nov 15 16:00 ET
- 1.620
- +0.025+1.57%
Post 19:59 ET
436.81MMarket Cap-1092P/E (TTM)
1.880High1.560Low22.76MVolume1.880Open1.855Pre Close37.82MTurnover8.36%Turnover RatioLossP/E (Static)273.86MShares10.65052wk High0.96P/B434.17MFloat Cap1.16052wk Low--Dividend TTM272.21MShs Float53.690Historical High--Div YieldTTM17.25%Amplitude1.060Historical Low1.661Avg Price1Lot Size
Pacific Biosciences of California Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -28.23%39.97M | -24.30%36.01M | -0.23%38.81M | 56.29%200.52M | 113.35%58.36M | 72.36%55.69M | 34.13%47.57M | 17.26%38.9M | -1.69%128.3M | -24.06%27.35M |
| Operating revenue | -28.23%39.97M | -24.30%36.01M | -0.23%38.81M | 56.29%200.52M | 113.35%58.36M | 72.36%55.69M | 34.13%47.57M | 17.26%38.9M | -1.69%128.3M | -24.06%27.35M |
| Cost of revenue | -20.71%29.96M | -6.09%30.08M | -5.53%27.53M | 86.38%147.74M | 119.63%48.79M | 101.39%37.79M | 66.17%32.03M | 53.22%29.14M | 10.63%79.27M | 15.37%22.21M |
| Gross profit | -44.12%10M | -61.80%5.94M | 15.58%11.28M | 7.64%52.78M | 86.21%9.57M | 32.15%17.9M | -4.00%15.55M | -31.04%9.76M | -16.69%49.04M | -69.34%5.14M |
| Operating expense | -20.48%72.91M | 2.12%88.58M | 4.46%92.71M | 2.63%363.15M | 9.51%95.96M | 9.30%91.69M | -3.19%86.75M | -4.30%88.76M | 49.29%353.85M | 9.68%87.63M |
| Selling and administrative expenses | 0.73%43.75M | 13.07%45.88M | 9.88%43.75M | 5.57%169.82M | 2.21%46M | 18.04%43.43M | 3.37%40.57M | 0.04%39.82M | 29.59%160.85M | 20.59%45M |
| Research and development costs | -46.30%25.52M | -16.65%38.49M | -11.21%43.46M | -3.02%187.17M | 4.51%44.54M | 0.90%47.51M | -8.29%46.17M | -7.55%48.94M | 70.95%193M | 0.11%42.62M |
| Depreciation amortization depletion | 392.44%3.65M | --4.22M | --5.51M | --6.16M | --5.42M | --741K | --0 | --0 | --0 | --0 |
| -Depreciation and amortization | 392.44%3.65M | --4.22M | --5.51M | --6.16M | --5.42M | --741K | --0 | --0 | --0 | --0 |
| Operating profit | 14.74%-62.91M | -16.08%-82.65M | -3.08%-81.43M | -1.82%-310.37M | -4.73%-86.39M | -4.90%-73.78M | 3.01%-71.2M | -0.52%-79M | -71.09%-304.82M | -30.66%-82.49M |
| Net non-operating interest income expense | 1.39%-3.54M | 0.34%-3.54M | 1.52%-3.58M | 2.36%-14.34M | 2.11%-3.57M | 2.07%-3.59M | 3.45%-3.55M | 1.81%-3.63M | -17.24%-14.69M | -4.86%-3.65M |
| Non-operating interest expense | -1.39%3.54M | -0.34%3.54M | -1.52%3.58M | -2.36%14.34M | -2.11%3.57M | -2.07%3.59M | 0.77%3.55M | 2.43%3.63M | 17.24%14.69M | -5.44%3.65M |
| Other net income (expense) | 2,917.73%5.72M | -1,870.60%-87.13M | 226.72%6.83M | 24.48%6.55M | 312.57%7.22M | 93.16%-203K | -13.58%4.92M | -787.37%-5.39M | 106.25%5.26M | 213.27%1.75M |
| Special income (charges) | 86.56%-1.17M | -2,225.35%-93.2M | 100.57%70K | -999.50%-26.14M | 74.71%-1.16M | -103.46%-8.71M | -173.70%-4.01M | -1,252.96%-12.26M | 97.18%-2.38M | -197.41%-4.6M |
| -Less：Restructuring and merger&acquisition | -86.56%1.17M | --0 | -100.57%-70K | 913.97%24.1M | -74.71%1.16M | 103.46%8.71M | 136.32%1.98M | 1,252.96%12.26M | -92.63%2.38M | 197.41%4.6M |
| -Less:Impairment of capital assets | --0 | --93.2M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --2.03M | --0 | ---- | --2.03M | ---- | ---- | ---- |
| Other non- operating income (expenses) | -18.99%6.89M | -32.03%6.07M | -1.57%6.76M | 327.91%32.68M | 32.06%8.38M | 547.75%8.51M | 3,387.89%8.93M | 2,561.29%6.87M | 8,112.90%7.64M | 634,700.00%6.35M |
| Income before tax | 21.72%-60.73M | -148.19%-173.32M | 11.18%-78.18M | -1.24%-318.16M | 1.95%-82.74M | -0.78%-77.58M | 2.19%-69.83M | -8.00%-88.02M | -14.33%-314.25M | -23.81%-84.38M |
| Income tax | 0 | 0 | 0 | -11.42M | -718K | -10.71M | 0 | 0 | 0 | 0 |
| Net income | 9.19%-60.73M | -148.19%-173.32M | 11.18%-78.18M | 2.39%-306.74M | 2.80%-82.02M | 13.12%-66.87M | 2.19%-69.83M | -8.00%-88.02M | -73.40%-314.25M | -21.72%-84.38M |
| Net income continuous Operations | 9.19%-60.73M | -148.19%-173.32M | 11.18%-78.18M | 2.39%-306.74M | 2.80%-82.02M | 13.12%-66.87M | 2.19%-69.83M | -8.00%-88.02M | -73.40%-314.25M | -21.72%-84.38M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 9.19%-60.73M | -148.19%-173.32M | 11.18%-78.18M | 2.39%-306.74M | 2.80%-82.02M | 13.12%-66.87M | 2.19%-69.83M | -8.00%-88.02M | -73.40%-314.25M | -21.72%-84.38M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 9.19%-60.73M | -148.19%-173.32M | 11.18%-78.18M | 2.39%-306.74M | 2.80%-82.02M | 13.12%-66.87M | 2.19%-69.83M | -8.00%-88.02M | -73.40%-314.25M | -21.72%-84.38M |
| Basic earnings per share | 15.38%-0.22 | -128.57%-0.64 | 19.44%-0.29 | 13.57%-1.21 | 16.22%-0.31 | 23.53%-0.26 | 12.50%-0.28 | 2.70%-0.36 | -57.30%-1.4 | -19.35%-0.37 |
| Diluted earnings per share | 15.38%-0.22 | -128.57%-0.64 | 19.44%-0.29 | 13.57%-1.21 | 16.22%-0.31 | 23.53%-0.26 | 12.50%-0.28 | 2.70%-0.36 | -57.30%-1.4 | -19.35%-0.37 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data